rs35902264

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000476.3(AK1):​c.484G>A​(p.Ala162Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00271 in 1,606,966 control chromosomes in the GnomAD database, including 74 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A162G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0075 ( 17 hom., cov: 33)
Exomes 𝑓: 0.0022 ( 57 hom. )

Consequence

AK1
NM_000476.3 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.104

Publications

6 publications found
Variant links:
Genes affected
AK1 (HGNC:361): (adenylate kinase 1) This gene encodes an adenylate kinase enzyme involved in energy metabolism and homeostasis of cellular adenine nucleotide ratios in different intracellular compartments. This gene is highly expressed in skeletal muscle, brain and erythrocytes. Certain mutations in this gene resulting in a functionally inadequate enzyme are associated with a rare genetic disorder causing nonspherocytic hemolytic anemia. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. This gene shares readthrough transcripts with the upstream ST6GALNAC6 gene. [provided by RefSeq, Jan 2022]
AK1 Gene-Disease associations (from GenCC):
  • hemolytic anemia due to adenylate kinase deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005394697).
BP6
Variant 9-127868353-C-T is Benign according to our data. Variant chr9-127868353-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 376798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00751 (1144/152300) while in subpopulation SAS AF = 0.0274 (132/4822). AF 95% confidence interval is 0.0236. There are 17 homozygotes in GnomAd4. There are 572 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AK1NM_000476.3 linkc.484G>A p.Ala162Thr missense_variant Exon 6 of 7 ENST00000644144.2 NP_000467.1 P00568Q6FGX9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AK1ENST00000644144.2 linkc.484G>A p.Ala162Thr missense_variant Exon 6 of 7 NM_000476.3 ENSP00000494600.1 P00568
ENSG00000257524ENST00000646171.1 linkn.*517G>A non_coding_transcript_exon_variant Exon 12 of 13 ENSP00000495484.1 A0A2R8YFX0
ENSG00000257524ENST00000646171.1 linkn.*517G>A 3_prime_UTR_variant Exon 12 of 13 ENSP00000495484.1 A0A2R8YFX0

Frequencies

GnomAD3 genomes
AF:
0.00752
AC:
1144
AN:
152182
Hom.:
17
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0230
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00270
Gnomad SAS
AF:
0.0274
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00479
GnomAD2 exomes
AF:
0.00506
AC:
1207
AN:
238538
AF XY:
0.00564
show subpopulations
Gnomad AFR exome
AF:
0.0233
Gnomad AMR exome
AF:
0.000780
Gnomad ASJ exome
AF:
0.000102
Gnomad EAS exome
AF:
0.00300
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000838
Gnomad OTH exome
AF:
0.00321
GnomAD4 exome
AF:
0.00220
AC:
3207
AN:
1454666
Hom.:
57
Cov.:
32
AF XY:
0.00276
AC XY:
1997
AN XY:
722880
show subpopulations
African (AFR)
AF:
0.0227
AC:
759
AN:
33388
American (AMR)
AF:
0.000915
AC:
40
AN:
43704
Ashkenazi Jewish (ASJ)
AF:
0.0000385
AC:
1
AN:
25978
East Asian (EAS)
AF:
0.00144
AC:
57
AN:
39518
South Asian (SAS)
AF:
0.0247
AC:
2098
AN:
84996
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52706
Middle Eastern (MID)
AF:
0.00293
AC:
16
AN:
5452
European-Non Finnish (NFE)
AF:
0.0000343
AC:
38
AN:
1108814
Other (OTH)
AF:
0.00329
AC:
198
AN:
60110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
248
496
743
991
1239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00751
AC:
1144
AN:
152300
Hom.:
17
Cov.:
33
AF XY:
0.00768
AC XY:
572
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0229
AC:
953
AN:
41560
American (AMR)
AF:
0.00163
AC:
25
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00270
AC:
14
AN:
5182
South Asian (SAS)
AF:
0.0274
AC:
132
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68020
Other (OTH)
AF:
0.00474
AC:
10
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
55
109
164
218
273
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00269
Hom.:
6
Bravo
AF:
0.00742
ESP6500AA
AF:
0.0202
AC:
89
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00569
AC:
691
Asia WGS
AF:
0.0120
AC:
40
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 10, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hemolytic anemia due to adenylate kinase deficiency Benign:1
Mar 16, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
2.4
DANN
Benign
0.92
DEOGEN2
Benign
0.32
T;T;T;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.085
N
LIST_S2
Benign
0.75
.;.;T;T
MetaRNN
Benign
0.0054
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;L;L;.
PhyloP100
0.10
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.54
N;.;N;N
REVEL
Benign
0.11
Sift
Benign
0.51
T;.;T;T
Sift4G
Benign
0.57
T;.;T;T
Polyphen
0.017
B;B;B;.
Vest4
0.079
MVP
0.58
MPC
0.29
ClinPred
0.0020
T
GERP RS
-2.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.12
gMVP
0.36
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35902264; hg19: chr9-130630632; API